What is Ankle Osteoarthritis
Ankle osteoarthritis (OA) is a degenerative joint disease that occurs when the cartilage cushioning the bones in the ankle joint (typically the tibiotalar joint) gradually wears away. Unlike hip or knee OA, ankle arthritis is often post-traumatic, meaning it typically develops after an injury like a fracture, ligament tear, or severe sprain. Over time, this cartilage loss leads to pain, stiffness, and reduced mobility.
Sign and Symptoms
Signs of Ankle Osteoarthritis
- Persistent swelling around the ankle joint, especially after activity.
- Difficulty moving the foot up, down, or side to side.
- A grinding or cracking sensation when moving the joint.
- Advanced OA can lead to visible changes in the shape of the ankle joint.
- The ankle may feel weak or give way easily.
Symptoms of Ankle Osteoarthritis
- Ongoing, deep, aching pain that worsens with activity and improves with rest.
- Especially noticeable in the morning or after long periods of inactivity.
- Pain when pressing on the joint or moving the ankle.
- Pain may lead to limping or altered gait patterns.
- Bony growths can form around the joint, leading to further discomfort and limited motion.
- Joint may feel warm and swollen, especially after prolonged use.
Common Causes of Ankle Osteoarthritis
- Fractures, dislocations, or severe sprains.
- Natural aging and joint overuse.
- Increased weight puts additional stress on the joint.
- Family history of arthritis can increase the risk.
- Conditions like rheumatoid arthritis can also affect the ankle.
Treat Ankle Osteoarthritis without Surgery
ORTHOReNEW powered by Regenexx USA offers advanced, non-surgical regenerative therapies for ankle osteoarthritis (OA) that aim to reduce pain, restore function, and potentially slow the progression of joint degeneration. These treatments are designed to stimulate the body’s natural repair processes and reduce inflammation, providing a promising alternative to traditional surgeries like ankle fusion or joint replacement.
ORTHOReNEW - Regenexx-SD Injectate
Procedures using Regenexx-SD injectate include a patented protocol that utilizes Bone Marrow Concentrate (BMC), which contains the patient’s own mesenchymal stem cells. The cell processing for a Regenexx-SD injectate routinely achieves 20x concentration— above what non-Regenexx cell processing can achieve.
ORTHOReNEW - Regenexx-SCP Injectate
Procedures using Regenexx-SCP injectate represent a supercharged version of platelet-rich plasma (PRP). In this process, blood is drawn, then processed to isolate the platelets and growth factors. The growth factors are then purified, concentrated, and injected into the hip area using imaging guidance for precision. Regenexx-SCP injectate provides a higher concentration of growth factors than typical PRP procedures.